Importantly, this prognostic function was independent of systemic inflammation, liver and kidney function, other CRC tumor markers such as CEA and CA19-9 as well as clinical features like patients’ BMI, the primary CRC tumor side or the tumor burden in multivariate Cox-regression analysis (see Table 3). The gene discussed is CEACAM5; the disease is neoplasm.